EP Patent

EP1976521A2 — Sublingual fentanyl spray

Assigned to Insys Therapeutics Inc · Expires 2008-10-08 · 18y expired

What this patent protects

The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.

USPTO Abstract

The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.

Drugs covered by this patent

Patent Metadata

Patent number
EP1976521A2
Jurisdiction
EP
Classification
—
Expires
2008-10-08
Drug substance claim
No
Drug product claim
No
Assignee
Insys Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.